Investing

Today's Market Winners and Losers

The stock market is mixed Wednesday, with the Dow Jones Industrial Average up 0.14%, the Nasdaq down 0.14% and the S&P 500 up 0.05%. Today’s winner is a popular company trying to capitalize on increasing use of mobile technology, while today’s loser is a pharmaceutical company whose drug won’t be covered by a major insurer.

This is Wednesday’s biggest winner and loser.

Biggest Winner

Shares of Groupon Inc. (NASDAQ: GRPN) are up  8.74% to $5.10 on trading volume of 9.4 million shares. The daily-deals company on Wednesday announced it had introduced a mobile payment service for Apple Inc.’s (NASDAQ: AAPL) iPad and iPod Touch. The 52-week high is $31.14.

Biggest Loser

Shares of Questor Pharmaceuticals Inc. (NASDAQ: QCOR) are down 35.61% to $32.52 on trading volume of 10.8 million shares. Citron Research announced that Aetna Inc. (NYSE: AET) is dropping nearly all of its coverage for Questor’s drug to help treat multiple sclerosis and nephrotic syndrome, according to theflyonthewall.com.  The 52-week low is $24.14.

Samuel Weigley

Follow him on Twitter: SWeigley

100 Million Americans Are Missing This Crucial Retirement Tool

The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.

Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.

A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.

Click here to learn how to get a quote in just a few minutes.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.